Abbott to pay up to $1.35 billion for arthritis drug - Chicago Tribune
Abbott to pay up to $1.35 billion for arthritis drug
North Chicago-based Abbott will pay Mechelen, Belgium-based Galapagos $150 million upfront for rights to the drug, GLPG0634, the companies said in a statement Wednesday. If midstage clinical trials are successful, Abbott will pay another $200 million ...
Abbott to Pay Galapagos $150 Million Up Front for Arthritis Drug RightsBloomberg
all 68 news articlesÂ Â»
Publish Date: Thu, 01 Mar 2012 05:50:35 GMT